U.S. Department of Health and Human Services. The Health Consequences of Smoking: Nicotine Addiction, A Report of the Surgeon General 1988. Rockville, MD: Office on Smoking and Health, DHSS Publication no. (CDC) 88-8406.
U.S. Department of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress, A Report of the Surgeon General 1989. Rockville, MD: Office on Smoking and Health, DHSS Publication no. (CDC) 89-8411.
Siegel D, Grady D, Browner WS, Hulley SB. Risk factor modification after myocardial infarction. Ann Intern Med 1988;109:213-218.
Sparrow D, Dawber TR, Colton T. The influence of cigarette smoking on prognosis after a first myocardial infarction: A report from the Framingham Study. J Chronic Dis 1978;31:425-432.
Daly LE, Mulcahy R, Graham IM, Hickey N. Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. Br Med J 1983;287:324-326.
Hedback B, Perk J. Five-year results of a comprehensive rehabilitation programme after myocardial infarction. Eur Heart J 1987;8:234-242.
AHA Consensus Panel Statement. Preventing heart attack and death in patients with coronary disease. J Am Coll Cardiol 1995;26:292-294.
Tonnesen P, Norregaard J, Simonsen K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991;325:311-315.
Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. JAMA 1991;266:3133-3138.
Jorenby DE, Smith SS, Fiore MC, et al. Varying nicotine patch dose and type of smoking cessation counselling. JAMA 1995;274:1347-1352.
Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR. High-dose nicotine patch therapy. JAMA 1995;274:1353-1358.
Kozak J, Fagerström K, Sawe U. High-dose treatment with the nicotine patch. Int J Smoking Cessation 1995;4:26-28.
Krumholz HM, Cohen BJ, Tsevat J, Pasternak RC, Weinstein MC. Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol 1993; 6:1697-1702.
Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335: 1792-1798.
Khoury Z, Comans P, Keren A, Lerer T, Gavish A, Tzivoni D. Effects of transdermal nicotine patches on ambulatory ECG monitoring findings: A double-blind study in healthy smokers. Cardiovasc Drugs Ther 1996;10:179-184.
Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978;3:235-241.
Draize JH, Woodward G, Calvery HO. Methods of the study of initiation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Therap 944;82:377-419.
Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343:139-142.
Fiore MC, Kenford SL, Jorenby DE, Wetter DW, Smith SS, Baker TB. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatment. Chest 1994;105:524-533.
Hughes JR. Combined psychological and nicotine gum treatment for smoking: A critical review. J Subst Abuse 1991;3:337-350.
Grunberg NE, Popp KA, Bowen DJ, et al. Effects of chronic nicotine administration on insulin, glucose, epinephrine and norepinephrine. Life Sci 1988;42:161-170.
Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: Six-month results from two multicenter controlled clinical trials. JAMA 1991;266:3133-3138.
Sachs DPL, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counselling. Arch Intern Med 1993;153:1881-1890.
Hurt RD, Dale LC, Fredrickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: One-year outcome and percentage of nicotine replacement. JAMA 1994;271:595-600.